---
schema_version: "secwatch.filing_event.v1"
accession: "0000875320-24-000207"
form_type: "8-K"
ticker: "VRTX"
cik: "0000875320"
company_name: "VERTEX PHARMACEUTICALS INC / MA"
filed_at: "2024-08-16T23:59:59+00:00"
generated_at: "2026-05-31T08:55:35.222359+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Vertex extends Boston headquarters leases to 2044, adding renewal options

## Summary
- Extended combined ~1.1 million sq ft of office and lab space under two leases in Boston.
- Lease term extended from December 2028 to June 30, 2044, with options for two additional ten-year periods.
- Amendments signed with SNH Seaport LLC on August 15, 2024.
- Previous lease had a single 10-year extension option; new terms provide up to 20 additional years.

## SEC filing metadata
- accession: 0000875320-24-000207
- form_type: 8-K
- ticker: VRTX
- cik: 0000875320
- company_name: VERTEX PHARMACEUTICALS INC / MA
- filed_at: 2024-08-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/0000875320-24-000207-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/vrtx-20240815.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000875320-24-000207
- JSON: https://secwatch.observer/filing/0000875320-24-000207.json
- Plain text: https://secwatch.observer/filing/0000875320-24-000207.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.